4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001234066-04-000015
President and CEO sold 10,000 shares at $9.69 ($96,900)
- President and CEO acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HARRIS ROBERT B · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2004-04-05 | Exercise or conversion : show line 1 in the form | +10,000 | $3.85 | $38,500 | 61,121 | D |
| 2004-04-05 | Sale : show line 2 in the form | −10,000 | $9.69 | $96,900 | 51,121 | D |
| Open-market sales · 10,000 sh · avg $9.69 · $96,900 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2004-04-05 | Exercise or conversion : show line 3 in the form Options | −10,000 | 109,460 | D |
Loading xslF345X02/primary_doc.xml…